Surface Oncology (SURF) News Today → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free SURF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMill Creek clinic can now cure some skin cancers without surgerymsn.com - April 18 at 12:35 PMPathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinicfinance.yahoo.com - April 18 at 7:34 AMGritstone bio (GRTS) Price Target Decreased by 37.04% to 5.78msn.com - April 17 at 9:11 PMTargeted therapies outperform hundreds of other drugs in 'priming' lung cancer cells for destructionmsn.com - April 17 at 4:10 PMCompass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumorsfinance.yahoo.com - April 16 at 8:19 AMProvectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meetingfinance.yahoo.com - April 11 at 9:35 AMLook Up and See the Futuremsn.com - April 10 at 2:21 PMNotable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024finance.yahoo.com - April 9 at 5:25 PMExtracellular cell matrix stiffness may induce drug resistance of breast cancer cellsmsn.com - April 9 at 12:24 PMTargeted Therapy Revolution: For People With Cancers That Have A Special Factor Called HER2, The Drug Enhertu Is Now Approved Across Tumor Types- What To Ask Your Doctormsn.com - April 9 at 12:24 PMNvelop Therapeutics Launches with Dual Platforms for In Vivo Delivery of the Next Generation of Genetic Medicinesfinance.yahoo.com - April 9 at 12:24 PMOrthobond Secures De Novo Classification Grant for First-in-Class Antibacterial Surface Treatment Applied to a Spinal Devicebusinesswire.com - April 8 at 4:22 PMTempus Introduces Workspaces into its Lens Data Analytics Platformfinance.yahoo.com - April 6 at 12:15 PM23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024finance.yahoo.com - April 5 at 4:13 PMIs THIS what's causing mystery rise in colon cancers among young people? New research points to bacteria in the gut linked to processed food and not eating enough fibermsn.com - April 4 at 2:53 PMHow is Metastatic Breast Cancer Treated?msn.com - April 4 at 1:09 AMAnthony A.. Florence Jr's Net Worthbenzinga.com - April 3 at 10:09 AMInvestigators develop novel treatment for T-cell leukemias and lymphomasmsn.com - April 2 at 2:06 PMUsing cryo-shocked tumor cells to fight lung cancermsn.com - April 2 at 4:04 AMKyverna reports first use of KYV-101 for multiple sclerosis treatmentmsn.com - April 1 at 6:03 PMAdvances In Early Detection Methods For Cervical Cancermsn.com - April 1 at 8:02 AMBrave NJ mom conquers brain surgery fears — by singing Taylor Swift songs throughout the life-saving proceduremsn.com - March 30 at 7:14 PMNew Jersey woman sings Taylor Swift hits while awake during brain surgery: 'Eras Tour' in the O.R.msn.com - March 30 at 7:48 AMMulago surgeons restore knees, joints of 33 patientsmsn.com - March 29 at 5:19 AMClinical trial: Some sarcoma patients improve with T cell immunotherapymsn.com - March 28 at 7:19 PMUP’s Professor Zodwa Dlamini and Team SAMBAI secure $25M to tackle global cancer Inequitiesmsn.com - March 28 at 3:46 AMThe little-known bacteria behind the rising rates of cancer in under 40smsn.com - March 27 at 10:34 PMNot brushing your teeth and the other causes of rising cancer in the under 40smsn.com - March 27 at 12:34 PMLumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meetingfinance.yahoo.com - March 27 at 7:33 AM26 Anti-Aging Secrets That Could Add Years to Your Lifemsn.com - March 27 at 7:33 AM2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?msn.com - March 23 at 6:31 AMHow to Manage Anxiety and Depression When You Have Kidney Cancermsn.com - March 22 at 8:28 PMLungVax vaccine uses DNA technology to prevent lung cancermsn.com - March 22 at 2:48 AMConcomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancermsn.com - March 21 at 9:48 PMConstruction underway on $410 million Health First hospital complex on Merritt Islandmsn.com - March 21 at 4:47 PMBoston Scientific CEO compensation jumps 11% in 2023bizjournals.com - March 21 at 4:47 PMFlamingo at Greenville Zoo reunites with feathery friends after cancer treatment.msn.com - March 21 at 11:47 AMBioNTech Se (BNTX) Q4 2023 Earnings Call Transcriptmsn.com - March 20 at 3:45 PMJohns Hopkins cancer treatment spinout launches with $150M, establishes D.C.-area hubbizjournals.com - March 20 at 10:44 AMSurface Oncology CEO Rob Ross returns, with new $150M-backed startupbizjournals.com - March 20 at 10:44 AMZai Lab Limited: Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumorsfinanznachrichten.de - March 13 at 8:30 PMEarly clinical trial results show 'dramatic and rapid' regression of glioblastoma after next generation CAR-T therapymsn.com - March 13 at 8:30 PMLiving drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumorsmsn.com - March 13 at 8:30 PMHow 'Nyad' Helped Me Survive Cancermsn.com - March 8 at 8:58 AM10 menopause myths and why it’s not as bad as people saymsn.com - March 7 at 3:13 PMBiomunex Signs Exclusive Licensing Agreement With Institut Curie to Develop MAIT Engagers, a New Class of Bispecific Antibodies in Immuno-oncologyfinance.yahoo.com - March 4 at 10:12 AMPietro Signorile, gynecologist: ‘Endometriosis is a disease that affects our whole society’msn.com - March 3 at 12:54 AMPromising Combination Therapy May Help Target Triple-Negative Breast Cancermsn.com - February 28 at 7:44 PMSensory nerves appear to drive head and neck cancer growthmsn.com - February 28 at 2:43 PM9 Symptoms of Breast Cancer That Aren’t Lumps Every Woman Should Knowmsn.com - February 27 at 11:03 PM Get Surface Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SURF and its competitors with MarketBeat's FREE daily newsletter. Email Address New crypto project uncovers 2,050% in 65 days (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. SURF Media Mentions By Week SURF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SURF News Sentiment▼0.000.53▲Average Medical News Sentiment SURF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SURF Articles This Week▼52▲SURF Articles Average Week Get Surface Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for SURF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cartesian Therapeutics News Chimerix News Spero Therapeutics News LianBio News Freeline Therapeutics News Kinnate Biopharma News Karyopharm Therapeutics News Sagimet Biosciences News Theseus Pharmaceuticals News Vaxart News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SURF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surface Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.